Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in Pro-B cells

Molecular Endocrinology

Volumn 21, Issue 10, 2007, Pages 2503-2515

  Barclay, Johanna L ^a   Anderson, Stephen T ^a   Waters, Michael J ^a   Curlewis, Jon D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; JANUS KINASE; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GC RICH SEQUENCE; GENE EXPRESSION REGULATION; GROWTH HORMONE; HUMANS; JANUS KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTOR AP-1;

EID: 34948882658     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0498     Document Type: Article

References (49)

1. Krebs DL, Hilton DJ 2000 SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113:2813-2819
2. Alexander WS, Starr R, Metcalf D, Nicholson SE, Farley A, Elefanty AG, Brysha M, Kile BT, Richardson R, Baca M, Zhang JG, Willson TA, Viney EM, Sprigg NS, Rakar S, Corbin J, Mifsud S, DiRago L, Cary D, Nicola NA, Hilton DJ 1999 Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J Leukoc Biol 66:588-592
3. Alexander WS, Hilton DJ 2004 The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22:503-529
4. Auernhammer CJ, Melmed S 2001 The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest 108:1735-1740
5. Wormald S, Hilton DJ 2004 Inhibitors of cytokine signal transduction. J Biol Chem 279:821-824
6. Chikanza IC 1999 Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci 876:119-130
7. Greenhalgh CJ, Alexander WS 2004 Suppressors of cytokine signalling and regulation of growth hormone action. Growth Horm IGF Res 14:200-206
8. Reddy EP, Korapati K, Chaturvedi P, Rane S 2000 IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 19:2532-2547
9. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1-20
10. Rane SG, Reddy EP 2002 JAKs, STATs and Src kinases in hematopoiesis. Oncogene 21:3334-3358
11. Ram PA, Waxman DJ 1999 SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274:35553-35561
12. 2 augments IL-10 signaling and function. J Immunol 177:1092-1100
13. Magrangeas F, Bond HM, Denis S, Jacques Y, Minvielle S 2001 Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3). Biochem J 15:223-230
14. Badolato R BH, Valerio G, Petrella A, Morrone G, Waters MJ, Venuta S, Tenore A 1994 Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J Clin Endocrinol Metab 79:984-990
15. Jeay S, Sonenshein GE, Kelly PA, Postel-Vinay M-C, Baixeras E 2001 Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-κB and phosphatidylinositol 3-kinase. Endocrinology 142:147-156
16. Sumita K, Hattori N, Inagaki C 2005 Effects of growth hormone on the differentiation of mouse B-lymphoid precursors. J Pharmacol Sci 97:408-416
17. Baixeras E, Jeay S, Kelly PA, Postel-Vinay M-C 2001 The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line. Endocrinology 142:2968-2977
18. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N 1998 Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 273:1285-1287
19. Gatto L, Berlato C, Poli V, Tininini S, Kinjyo I, Yoshimura A, Cassatella MA, Bazzoni F 2004 Analysis of SOCS-3 promoter responses to interferon gamma. J Biol Chem 279:13746-13754
20. Ehlting C, Haussinger D, Bode JG 2005 Sp3 is involved in the regulation of SOCS3 gene expression. Biochem J 387:737-745
21. He B, You L, Uematsu K, Matsangou M, Xu Z, He M, McCormick F, Jablons DM 2003 Cloning and characterization of a functional promoter of the human SOCS-3 gene. Biochem Biophys Res Commun 301:386-391
22. Auernhammer CJ, Bousquet C, Melmed S 1999 Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 96:6964-6969
23. Bousquet C, Chesnokova V, Kariagina A, Ferrand A, Melmed S 2001 cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action. Mol Endocrinol 15:1880-1890
24. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E 2000 SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15985-15991
25. Paul C, Seiliez I, Thissen JP, Le Cam A 2000 Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur J Biochem 267:5849-5857
26. Barclay JL, Anderson ST, Waters MJ, Curlewis JD 2006 Regulation of SOCS3 expression by prolactin in breast cancer cells. Proc COMBIO2006 Annual Conference, Gold Coast, Australia, 2006, Sym-04-03, P40
27. Zhu T, Ling L, Lobie PE 2002 Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent. J Biol Chem 277:45592-45603
28. Manabe N, Kubota Y, Kitanaka A, Ohnishi H, Taminato T, Tanaka T 2006 Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells. Leuk Res 30:1391-1398
29. Yarwood SJ, Kilgour E, Anderson NG 1998 Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: possible involvement of the transcription factor CREB. Mol Cell Endocrinol 138:41-50
30. Kortylewski M, Feld F, Kruger K-D, Bahrenberg G, Roth RA, Joost H-G, Heinrich PC, Behrmann I, Barthel A 2003 Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism. J Biol Chem 278:5242-5249
31. Behncken SN, Billestrup N, Brown R, Amstrup J, Conway-Campbell B, Waters MJ 2000 Growth hormone (GH)-independent dimerization of GH receptor by a leucine zipper results in constitutive activation. J Biol Chem 275:17000-17007
32. Frasor J, Park K, Byers M, Telleria C, Kitamura T, Yu-Lee LY, Djiane J, Park-Sarge OK, Gibori G 2001 Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERα and ERβ transcription. Mol Endocrinol 15:2172-2181
33. Boucheron C, Dumon S, Santos SCR, Moriggl R, Hennighausen L, Gisselbrecht S, Gouilleux F 1998 A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities. J Biol Chem 273:33936-33941
34. Vidal OM, Merino R, Rico-Bautista E, Fernandez-Perez L, Chia DJ, Woelfle J, Ono M, Lenhard B, Norstedt G, Rotwein P, Flores-Morales A 2007 In vivo transcript profiling and phylogenetic analysis identifies SOCS2 as a direct STAT5b target in liver. Mol Endocrinol 21:293-311
35. Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F 1996 Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:5691-5700
36. Stocklin E, Wissler M, Gouilleux F, Groner B 1996 Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728
37. Pfitzner E, Jahne R, Wissler M, Stoecklin E, Groner B 1998 p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol Endocrinol 12:1582-1593
38. Sumantran VN, Tsai ML, Schwartz J 1992 Growth hormone induces c-fos and c-jun expression in cells with varying requirements for differentiation. Endocrinology 130:2016-2024
39. Xu A, Wong LC, Wang Y, Xu JY, Cooper GJS, Lam KSL 2004 Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Lett 572:129-134
40. Zhu T, Lobie PE 2000 Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J Biol Chem 275:2103-2114
41. Ling L, Zhu T, Lobie PE 2003 Src-CrkII-C3G-dependent activation of Rap1 switches growth hormone-stimulated p44/42 MAP kinase and JNK/SAPK activities. J Biol Chem 278:27301-27311
42. Zhu T, Goh ELK, LeRoith D, Lobie PE 1998 Growth hormone stimulates the formation of a multiprotein signaling complex involving p130Cas and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem 273:33864-33875
43. Guha M, Mackman N 2001 LPS induction of gene expression in human monocytes. Cell Signal 13:85-94
44. Tanos T, Marinissen MJ, Leskow FC, Hochbaum D, Martinetto H, Gutkind JS, Coso OA 2005 Phosphorylation of c-Fos by members of the p38 MAPK family: role in the AP-1 response to UV light. J Biol Chem 280:18842-18852
45. Vogt PK, Jiang H, Aoki M 2005 Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4:908-913
46. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM 2004 FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23:4802-4812
47. Dijkers PF, Medema RH, Lammers J-WJ, Koenderman L, Coffer PJ 2000 Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. CurrBiol 10:1201-1204
48. Wan Y, McDevitt A, Shen B, Smythe ML, Waters MJ 2004 Increased site 1 affinity improves biopotency of porcine growth hormone: evidence against diffusion dependent receptor dimerization. J Biol Chem 279:44775-44784
49. 2 in T47D cells. Mol Endocrinol 21:2516-2528